Chemotherapy of an experimental Fusobacterium (Sphaerophorus) necrophorum infection in mice

Insights

A new mouse model effectively tests antibiotics against Fusobacterium necrophorum infections. Tetracycline demonstrated superior efficacy compared to clindamycin, penicillin-G, and lincomycin in this in vivo study.

Area of Science:

  • Veterinary Microbiology
  • Pharmacology
  • Infectious Diseases

Background:

  • Fusobacterium necrophorum is a significant pathogen in animal infections.
  • Effective in vivo models are crucial for evaluating antibiotic efficacy.
  • Limited data exists on comparative antibiotic effectiveness against F. necrophorum.

Purpose of the Study:

  • To develop and validate an experimental animal model for testing antibiotics against Fusobacterium necrophorum.
  • To compare the in vivo efficacy of tetracycline, clindamycin, penicillin-G, and lincomycin.

Main Methods:

  • Subcutaneous injection of F. necrophorum into mice.
  • Intraperitoneal administration of antibiotics at 24, 48, 72, and 96 hours post-infection.
  • Assessment of survival rates at 21 days to determine Mean Effective Dose (MED).

Main Results:

  • Tetracycline exhibited the highest efficacy with a MED of 5.0 mg/kg.
  • Clindamycin (MED 11.1 mg/kg) and penicillin-G (MED 11.8 mg/kg) showed moderate effectiveness.
  • Lincomycin displayed the lowest efficacy with a MED of 52.9 mg/kg.

Conclusions:

  • The developed mouse model is suitable for in vivo antibiotic testing against F. necrophorum.
  • Tetracycline is the most effective antibiotic among those tested for F. necrophorum infections in this model.
  • Findings provide valuable data for selecting appropriate antibiotic treatments for F. necrophorum related diseases.

Related Concept Videos